New Zealand markets closed

Aridis Pharmaceuticals, Inc. (ARDS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.3500-0.0800 (-2.33%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
33
1,000
1,022
2,757
860
Cost of revenue
-
-
-
-
0
Gross profit
-
-
-
-
860
Operating expenses
Research development
17,920
16,956
24,083
23,000
17,438
Selling general and administrative
6,861
6,445
6,026
3,874
3,160
Total operating expenses
24,781
23,401
30,109
26,874
20,598
Operating income or loss
-24,748
-22,401
-29,087
-24,117
-19,738
Interest expense
-
-
-
420
-
Total other income/expenses net
751
-9
-951
1,592
-5,152
Income before tax
-23,990
-22,333
-29,681
-22,105
-24,656
Income from continuing operations
-23,990
-22,333
-29,681
-22,105
-24,656
Net income
-23,990
-22,333
-29,681
-22,105
-24,656
Net income available to common shareholders
-24,976
-22,333
-29,681
-23,462
-27,449
Basic EPS
-
-2.44
-3.51
-7.02
-3.48
Diluted EPS
-
-2.44
-3.51
-7.02
-3.48
Basic average shares
-
9,169
8,458
3,147
7,890
Diluted average shares
-
9,169
8,458
3,147
7,890
EBITDA
-
-22,064
-28,749
-23,834
-19,676